Sangamo Therapeutics
SGMO
#10572
Rank
NZ$55.79 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-81.42%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: NZ$55.79 Million

As of November 2026 Sangamo Therapeutics has a market cap of NZ$55.79 Million. This makes Sangamo Therapeutics the world's 10572th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$55.79 M-77.4%
2025NZ$0.24 B-73.93%
2024NZ$0.94 B521.62%
2023NZ$0.15 B-81.2%
2022NZ$0.81 B-49.33%
2021NZ$1.59 B-47.71%
2020NZ$3.05 B112.24%
2019NZ$1.44 B-17.59%
2018NZ$1.74 B-10.39%
2017NZ$1.95 B527.64%
2016NZ$0.31 B-66.87%
2015NZ$0.93 B-30%
2014NZ$1.34 B27.43%
2013NZ$1.05 B171.41%
2012NZ$0.38 B103.01%
2011NZ$0.19 B-51.11%
2010NZ$0.39 B6.5%
2009NZ$0.36 B49.23%
2008NZ$0.24 B-64.14%
2007NZ$0.68 B108.74%
2006NZ$0.32 B82.15%
2005NZ$0.18 B-15.17%
2004NZ$0.21 B1.2%
2003NZ$0.20 B47.57%
2002NZ$0.14 B-74.16%
2001NZ$0.55 B-43.5%
2000NZ$0.97 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.221 T 2,188,337.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$450.81 B 807,860.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$67.47 B 120,823.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ$41.32 B 73,970.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$384.34 B 688,739.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$643.26 B 1,152,778.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$38.14 B 68,272.56%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$20.62 B 36,866.89%๐Ÿ‡บ๐Ÿ‡ธ USA